Samsara Vision, Inc. (Europe)

  • En
  • SING IMT™
  • AMD
  • Patients & Caregivers
    • Overview
    • Patient Journey
    • Patient Expectations
    • Clinical Trial Outcomes
    • Vision & AMD Patient Resources
    • Important Safety Information
  • Healthcare Providers
    • Technology
    • Ultra-Precision Micro-Optics
    • Clinical Safety and Efficacy Data
    • Scientific Publications
  • Contact
  • Company
    • Overview
    • Executive Team
    • Board of Directors
    • European Leadership Team
    • For Investors
    • Career Opportunities
  • Media

Media

Jan 13, 2025

Samsara Vision Announces Positive Six-Month Visual and Safety Outcomes from the SING IMT® (Smaller-Incision New-Generation Implantable Miniature Telescope)

Sep 3, 2024

Samsara Vision Promotes Jason Herod to Chief Commercial Officer

Jul 22, 2024

Samsara Vision Announces First SING IMT® (Smaller-Incision New-Generation Implantable Miniature Telescope) Patient in China and Accelerating Global Rollout

Mar 10, 2022

Samsara Vision erhält Entgeltvereinbarung NUB Status 1 für SING IMT™

Mar 10, 2022

Awarded NUB Status 1 Reimbursement Designation for SING IMT™

Feb 22, 2022

I primi 3 pazienti italiani ricevono il SING IMT™ di Samsara Vision, una nuova tecnologia per la degenerazione maculare legata all'età

Feb 22, 2022

Italian Patients Receive Samsara Vision’s SING IMT™, a New Technology for Age-Related Macular Degeneration

RSS

Need More Information?

Get More Info
© 2025 Samsara Vision, Inc. (Europe). All Rights Reserved.
Privacy Policy Disclaimer Sitemap